4.4 Review

Multiplex Molecular Point-of-Care Test for Syndromic Infectious Diseases

期刊

BIOCHIP JOURNAL
卷 15, 期 1, 页码 14-22

出版社

KOREAN BIOCHIP SOCIETY-KBCS
DOI: 10.1007/s13206-021-00004-5

关键词

Multiplex molecular point-of-care testing; Syndromic infectious disease; Molecular diagnosis; POCT

资金

  1. National Research Foundation of Korea (NRF) - Korean government (the Ministry of Science and ICT) [2019R1A2C2087631, 2016M3A9B6919189, 2016M3A9B6919187]
  2. Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT) [202011A04]
  3. Korea Medical Device Development Fund - Korea government (the Ministry of Trade, Industry, and Energy) [202011A04]
  4. Korea Medical Device Development Fund - Korea government (the Ministry of Health & Welfare, Republic of Korea) [202011A04]
  5. Korea Medical Device Development Fund - Korea government (the Ministry of Food and Drug Safety) [202011A04]
  6. Samsung Research Funding & Incubation Center of Samsung Electronics [SRFC-IT1902-05]
  7. National Research Foundation of Korea [2016M3A9B6919189, 2019R1A2C2087631, 2016M3A9B6919187] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

The paragraph discusses the transition from single-pathogen detection to syndromic approach with multiplex capabilities in point-of-care molecular diagnostics, highlighting the higher accuracy and standardized antibiotic usage it provides in critical care settings. It also mentions the simplicity of operation in primary care and remote settings without laboratory infrastructure.
Point-of-care (POC) molecular diagnostics for clinical microbiology and virology has primarily focused on the detection of a single pathogen. More recently, it has transitioned into a comprehensive syndromic approach that employs multiplex capabilities, including the simultaneous detection of two or more pathogens. Multiplex POC tests provide higher accuracy to for actionable decisionmaking in critical care, which leads to pathogen-specific treatment and standardized usages of antibiotics that help prevent unnecessary processes. In addition, these tests can be simple enough to operate at the primary care level and in remote settings where there is no laboratory infrastructure. This review focuses on state-of-the-art multiplexed molecular point-of-care tests (POCT) for infectious diseases and efforts to overcome their limitations, especially related to inadequate throughput for the identification of syndromic diseases. We also discuss promising and imperative clinical POC approaches, as well as the possible hurdles of their practical applications as front-line diagnostic tests.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据